For Food Companies, Shifts From GLP-1 Use Are Hard to Digest

For Food Companies, Shifts From GLP-1 Use Are Hard to Digest — Live Feedhttps://www.live-feeds.com/feed/for-food-companies-shifts-from-glp-1-use-are-hard-to-digestContinuously updated, source-cited coverage. GLP-1 Weight Loss Drugs Put $73 Billion in Food Brand Value at Riskhttps://www.live-feeds.com/feed/for-food-companies-shifts-from-glp-1-use-are-hard-to-digesthttps://www.live-feeds.com/feed/for-food-companies-shifts-from-glp-1-use-are-hard-to-digest#u77027Sun, 20 Sep 2026 03:16:23 +0000The rise of GLP-1 medications like Ozempic is forcing global food companies to adapt their product mixes as consumer eating habits shift. A Brand Finance report indicates these drugs threaten $73 billion in global food brand value. Major retailers and food giants, including Costco, Kroger, and PepsiCo, face potential revenue losses from decreased appetite and changing shopper preferences. PepsiCo has specifically identified these drugs as a major risk to its brand mix as the industry grapples with a shrinking market for traditional high-calorie goods.Why it mattersGLP-1 drugs mimic hormones th